Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Repligen Corp (NASDAQ:RGEN)

30.19
Delayed Data
As of Sep 30
 +0.65 / +2.20%
Today’s Change
20.07
Today|||52-Week Range
36.00
+6.72%
Year-to-Date
No recent news for Repligen Corp.

Today’s Trading

Previous close29.54
Today’s open29.80
Day’s range29.31 - 30.60
Volume410,713
Average volume (3 months)282,412
Market cap$998.1M
Dividend yield--
Data as of 3:59pm ET, 09/30/2016

Growth & Valuation

Earnings growth (last year)+12.00%
Earnings growth (this year)+57.14%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+31.45%
P/E ratio125.8
Price/Sales11.37
Price/Book7.93

Competitors

 Today’s
change
Today’s
% change
XNCRXencor Inc+0.11+0.45%
LCILannett Company Inc-0.22-0.82%
MGNXMacroGenics Inc+0.48+1.63%
ACORAcorda Therapeutics ...+0.24+1.16%
Data as of 4:03pm ET, 09/30/2016

Financials

Next reporting dateNovember 3, 2016
EPS forecast (this quarter)$0.08
Annual revenue (last year)$83.5M
Annual profit (last year)$9.3M
Net profit margin11.19%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Tony J. Hunt
Vice President-
Global Operations
Steve Curran
Corporate headquarters
Waltham, Massachusetts

Forecasts

Search for Jobs